Impact of gender on outcomes after transcatheter aortic valve implantation
- PMID: 30108610
- PMCID: PMC6087513
- DOI: 10.11909/j.issn.1671-5411.2018.06.013
Impact of gender on outcomes after transcatheter aortic valve implantation
Abstract
Backgound: The influence of gender on clinical outcomes following transcatheter aortic valve implantation (TAVI) was considerably discrepant in previous studies. We aimed to investigate the impact of gender in our registry.
Methods: The study is a retrospective observational analysis of a prospectively designed cohort (546 consecutive patients treated at the University Hospital Zurich who were enrolled in Swiss TAVI Cohort from May 2008 to April 2014). The Study took place in University Heart Centre at University Hospital Zurich, Switzerland.
Results: Both genders were equally represented with 51.5 % (n = 281) of the populations being females, who were significantly older and had a more pronounced history of hypertension (P < 0.001). Males on the other hand showed a higher incidence of diabetes (P = 0.004), coronary artery disease (P < 0.001), chronic obstructive pulmonary disease (P < 0.001) and renal failure requiring renal replacement therapy (P = 0.018). Patients were followed up for a median of 391 days with a 100% complete follow-up at one year. The primary outcome (all-cause mortality) occurred in 6.8% (n = 37) and 15% (n = 82) of patients at 30 days and one year, respectively. The 30-day all-cause mortality outcome did not significantly differ between females (7.5%) and males (6.0%) (P = 0.619), but one year all-cause mortality occurred significantly more in males than in females (18.7% vs. 11.7%, P < 0.037).
Conclusion: After TAVI implantation for severe aortic stenosis, males have a less favorable long-term (one year) mortality outcome than females.
Keywords: Aortic stenosis; Aortic valve; Gender; Transcatheter aortic valve implantation.
Figures
Similar articles
-
The hospital results and 1-year outcomes of transcatheter aortic valve-in-valve procedures and transcatheter aortic valve implantations in the native valves: the results from the Swiss-TAVI Registry.Eur J Cardiothorac Surg. 2019 Jul 1;56(1):55-63. doi: 10.1093/ejcts/ezy471. Eur J Cardiothorac Surg. 2019. PMID: 30689870
-
Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry.EuroIntervention. 2014 Dec;10(8):982-9. doi: 10.4244/EIJV10I8A166. EuroIntervention. 2014. PMID: 24694729
-
Short and long-term clinical impact of transcatheter aortic valve implantation in Portugal according to different access routes: Data from the Portuguese National Registry of TAVI.Rev Port Cardiol (Engl Ed). 2020 Dec;39(12):705-717. doi: 10.1016/j.repc.2020.02.014. Epub 2020 Nov 28. Rev Port Cardiol (Engl Ed). 2020. PMID: 33261991 English, Portuguese.
-
The predictive value of baseline pulmonary hypertension in early and long term cardiac and all-cause mortality after transcatheter aortic valve implantation for patients with severe aortic valve stenosis: A systematic review and meta-analysis.Cardiovasc Revasc Med. 2018 Oct-Nov;19(7 Pt B):859-867. doi: 10.1016/j.carrev.2018.03.015. Epub 2018 Mar 23. Cardiovasc Revasc Med. 2018. PMID: 29724516
-
Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials.Eur Heart J. 2016 Dec 14;37(47):3503-3512. doi: 10.1093/eurheartj/ehw225. Epub 2016 Jul 7. Eur Heart J. 2016. PMID: 27389906
Cited by
-
Sex difference and outcome trends following transcatheter aortic valve replacement.Front Cardiovasc Med. 2022 Oct 18;9:1013739. doi: 10.3389/fcvm.2022.1013739. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36329995 Free PMC article.
-
Long-Term Prognosis and Predictors of Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: A Retrospective Analysis.Cureus. 2023 Aug 31;15(8):e44432. doi: 10.7759/cureus.44432. eCollection 2023 Aug. Cureus. 2023. PMID: 37791197 Free PMC article.
-
TAVI Success Is More Than Just the Valve: CT-Derived Sarcopenia as a Major Determinant of Long-Term Survival.J Cachexia Sarcopenia Muscle. 2025 Aug;16(4):e70012. doi: 10.1002/jcsm.70012. J Cachexia Sarcopenia Muscle. 2025. PMID: 40643039 Free PMC article.
-
Does Gender Influence the Indication of Treatment and Long-Term Prognosis in Severe Aortic Stenosis?J Cardiovasc Dev Dis. 2023 Jan 22;10(2):38. doi: 10.3390/jcdd10020038. J Cardiovasc Dev Dis. 2023. PMID: 36826534 Free PMC article.
-
Microstructural alterations measured by diffusion tensor imaging following transcatheter aortic valve replacement and their association with cerebral ischemic injury and cognitive function - a prospective study.Neuroradiology. 2022 Dec;64(12):2343-2356. doi: 10.1007/s00234-022-03017-5. Epub 2022 Aug 1. Neuroradiology. 2022. PMID: 35915181 Free PMC article. Clinical Trial.
References
-
- Rodés-Cabaua J, Ureñaa M, Nombela-Francoa L. Indications for transcatheter aortic valve replacement based on the PARTNER trial. Rev Esp Cardiol. 2012;65:208–214. - PubMed
-
- Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755–763. - PubMed
-
- Grube E, Buellesfeld L, Mueller R, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve revalving system. Circ Cardiovasc Intervent. 2008;1:167–175. - PubMed
-
- Cribier A, Litzler PY, Eltchaninoff H, et al. Technique of transcatheter aortic valve implantation with the Edwards-Sapien heart valve using the transfemoral approach. Herz. 2009;34:347–356. - PubMed
-
- Iung B, Baron G, Butchart EG, et al. The Euro heart survey on valvular heart disease. Eur Heart J. 2003;24:1231–1243. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous